Development of a gene panel for immune status assessment in sepsis
The results support the potential utility of a four-gene panel to assess immune status and guide immunotherapy; further prospective validation and translational studies are warranted. Trial registration National Medical Research Registration and Filing Information of China, 2022ZDSYLL196-P01. Registered 26 May 2023, https://www.medicalresearch.org.cn/login.
Authors
- Xiaojing Wu (ORCID: https://orcid.org/0000-0002-8691-1619)
- Jianfeng Xie (ORCID: https://orcid.org/0000-0002-6097-9172)
- Yiwei Jiang
- Hanbing Chen (ORCID: https://orcid.org/0000-0001-9727-8719)
- Ying Tang (ORCID: https://orcid.org/0000-0003-4357-2343)
- Yen‐Hsuan Ni (ORCID: https://orcid.org/0000-0002-1158-5249)
- Ling Liu (ORCID: https://orcid.org/0000-0001-6431-6352)
- Haibo Qiu (ORCID: https://orcid.org/0000-0001-9360-6682)
- Jie Chao (ORCID: https://orcid.org/0000-0002-7800-3557)
- Xing Zhou
- Chenxuan Gao (ORCID: https://orcid.org/0000-0002-6933-1727)
- Xinxing Lu (ORCID: https://orcid.org/0009-0004-7521-4983)
- Yi Yang
Institutions
- Southeast University (BD)
- Zhongda Hospital Southeast University (CN)
- Southeast University (CN)
Publication Details
- Journal
- Annals of Intensive Care
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1186/s13613-025-01594-1
- Citations
- 3
- Primary Topic
- Sepsis Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.06
Funders
- National Natural Science Foundation of China
- Government of Jiangsu Province
- Natural Science Foundation of Jiangsu Province
- National Science and Technology Major Project